Skip to main content
. 2017 Jun 29;9:21–24. doi: 10.1016/j.jcte.2017.06.004

Table 3.

Comparisons between women with NGT or AGT.

NGT AGT P-value
N (%) 19 (19) 81 (81)
Age (years) 38 ± 4 38 ± 5 0.82
Age at the diagnosis of GDM (years) 34 ± 5 34 ± 4 0.75
Gestational age at the diagnosis of GDM (weeks) 22 ± 9 20 ± 10 0.44
Time since delivery (months) 45 ± 23 46 ± 29 0.81
Family history of DM (%) 32 56 0.06
BMI (kg/m2)
 Before gestation 23.3 ± 6.1 24.9 ± 5.6 0.32
 At the diagnosis of GDM 26.0 ± 6.6 27.3 ± 5.5 0.40
 At enrolment into this study 25.7 ± 5.8 25.9 ± 5.2 0.89
Women diagnosed with GDM before 24 weeks of gestation (%) 42.1 53.8 0.361
PG (mg/dl)
 1 h after the 50 g-GCT 162 ± 18 186 ± 28 0.001
 During the 100 g-OGTT
 0 h 84 ± 15 88 ± 25 0.435
 1 h 180 ± 46 207 ± 32 0.024
 2 h 186 ± 20 195 ± 31 0.263
 3 h 153 ± 34 163 ± 75 0.55
Women with ≥3 abnormal PG values during the 100 g-OGTT (%) 15.8 50.7 0.006
HbA1c (%) 5.5 ± 0.4 6.4 ± 1.6 0.00
HOMA-%B 107 ± 33 104 ± 50 0.78
HOMA-IR (median [range]) 0.9 (0.5–2.1) 1.3 (0.4–4.0) 0.013

Data are presented as the mean ± standard deviation or percentage.

NGT: normal glucose tolerance; AGT: abnormal glucose tolerance; GDM: gestational diabetes mellitus; BMI: body mass index; GCT: glucose challenge test; OGTT: oral glucose tolerance test; HbA1c: hemoglobin A1c; HOMA-%B, homeostasis model assessment of β cell function; HOMA-IR: homeostasis model assessment of insulin resistance.